Cited by 167Blood Pressure and Hypertension StudiesDiabetes, Cardiovascular Risks, and LipoproteinsCardiovascular Health and Disease Prevention

Masked Hypertension in Diabetes Mellitus: Treatment Implications for Clinical Practice

Open access
Franklin, Stanley S., Thijs, Lutgarde, Li, Yan, Hansen, Tine W., Boggia, José, Liu, Yanping, Asayama, Kei, Björklund-Bodegård, Kristina +19 more·2013·Hypertension

Abstract

Although distinguishing features of masked hypertension in diabetics are well known, the significance of antihypertensive treatment on clinical practice decisions has not been fully explored. We analyzed 9691 subjects from the population-based 11-country International Database on Ambulatory Blood Pressure in Relation to Cardiovascular Outcomes. Prevalence of masked hypertension in untreated normotensive participants was higher ( P <0.0001) among 229 diabetics (29.3%, n=67) than among 5486 nondiabetics (18.8%, n=1031). Over a median of 11.0 years of follow-up, the adjusted risk for a composite cardiovascular end point in untreated diabetic-masked hypertensives tended to be higher than in normotensives (hazard rate [HR], 1.96; 95% confidence interval [CI], 0.97–3.97; P =0.059), similar to untreated stage 1 hypertensives (HR, 1.07; CI, 0.58–1.98; P =0.82), but less than stage 2 hypertensives (HR, 0.53; CI, 0.29–0.99; P =0.048). In contrast, cardiovascular risk was not significantly different in antihypertensive-treated diabetic-masked hypertensives, as compared with the normotensive comparator group (HR, 1.13; CI, 0.54–2.35; P =0.75), stage 1 hypertensives (HR, 0.91; CI, 0.49–1.69; P =0.76), and stage 2 hypertensives (HR, 0.65; CI, 0.35–1.20; P =0.17). In the untreated diabetic-masked hypertensive population, mean conventional systolic/diastolic blood pressure was 129.2±8.0/76.0±7.3 mm Hg, and mean daytime systolic/diastolic blood pressure 141.5±9.1/83.7±6.5 mm Hg. In conclusion, masked hypertension occurred in 29% of untreated diabetics, had comparable cardiovascular risk as stage 1 hypertension, and would require considerable reduction in conventional blood pressure to reach daytime ambulatory treatment goal. Importantly, many hypertensive diabetics when receiving antihypertensive therapy can present with normalized conventional and elevated ambulatory blood pressure that mimics masked hypertension.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/hypertensionaha.111.00289

Cites

62 of 62 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Franklin, S. S., Thijs, L., Li, Y., Hansen, T. W., Boggia, J., Liu, Y., Asayama, K., Björklund-Bodegård, K., Ohkubo, T., Jeppesen, J., Torp-Pedersen, C., Dolan, E., Kuznetsova, T., Stolarz-Skrzypek, K., Tikhonoff, V., Malyutina, S., Casiglia, E., Nikitin, Y., Lind, L., Sandoya, E., Kawecka-Jaszcz, K., Filipovský, J., Imai, Y., Wang, J., Ibsen, H., O’Brien, E., & Staessen, J. A.
Affiliations
  • University of California, Irvine (US)
  • From the Heart Disease Prevention Program, Division of Cardiology, School of Medicine, University of California, Irvine, California (S.S.F.); The Studies Coordinating Centre, Division of Hypertension and Cardiovascular Rehabilitation, Department of Cardiovascular Sciences, University of Leuven, Belgium (L.T., Y.L., K.A., T.K., J.A.S.); Department of Internal Medicine, Division of Hypertension, University Medical Centre Ljubljana, Slovenia (J.B.H.); Center for Epidemiological Studies and Clinical...
Venue
Hypertension
Published
2013-05
Volume
61
Issue
5
Pages
964-971
ISSN
  • 0194-911X (ISSN-L)
  • 1524-4563
OpenAlex
W2148484476
Cited by
167
References
62
Citations by year
2026: 4 · 2025: 10 · 2024: 9 · 2023: 9 · 2022: 16 · 2021: 8 · 2020: 19 · 2019: 13 · 2018: 17 · 2017: 9 · 2016: 18 · 2015: 10 · 2014: 17 · 2013: 8
FWCI
11.88
Type
journal article
Language
en
Licence
other-oa
Locations
  • Hypertension (publishedVersion)
  • PubMed (publishedVersion)
  • Research at the University of Copenhagen (University of Copenhagen) (publishedVersion)
  • Research Publications (Maastricht University) (acceptedVersion, other-oa)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
  • Homo Politicus (Academy of Humanities and Economics in Lodz) (submittedVersion)
  • Jagiellonian University Repository (Jagiellonian University) (submittedVersion, cc-by-nc-nd)
  • Homo Politicus (Academy of Humanities and Economics in Lodz) (submittedVersion, cc-by-nc-nd)
  • Lirias (submittedVersion)
  • Padua Research Archive (University of Padova) (submittedVersion)
  • Research Publications (Maastricht University) (submittedVersion, other-oa)
Funders
  • Hjerteforeningen (01-2-9-9A-22914)
  • European Commission (LSHM-CT-2006-037093, 201550, IC15-CT98-0329-EPOGH, 278249)
  • Ministry of Education, Culture, Sports, Science and Technology (23390171, 23790242, 23249036)
  • National Natural Science Foundation of China (30871360, 30871081)
  • Ministry of Health, Labour and Welfare
  • Universidad de la República Uruguay (IC15-CT98-0329-EPOGH)
  • Vlaamse regering
  • H. Lundbeck A/S
  • Japan Society for the Promotion of Science (25253059)
  • Comisión Sectorial de Investigación Científica
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Disease Prevention
Keywords
masked hypertension, diabetes mellitus, antihypertensive therapy, cardiovascular risk, ambulatory blood pressure, untreated hypertension, stage 1 hypertension, stage 2 hypertension, prevalence, cardiovascular outcomes, blood pressure reduction, ambulatory blood pressure monitoring, cardiovascular risk reduction
MeSH terms
Adult, Aged, Antihypertensive Agents, Blood Pressure, Blood Pressure Determination, Cardiovascular Diseases, Diabetes Mellitus, Female, Follow-Up Studies, Humans, International Cooperation, Male, Middle Aged, Practice Patterns, Physicians', Retrospective Studies, Risk Factors, Cohort Studies, Comorbidity, Prevalence, Treatment Outcome, Masked Hypertension

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review